SLOW ONSET ANTI-RHEUMATIC DRUGS IN RHEUMATOID-ARTHRITIS - COULD THE PRESENCE OF ANTI-NUCLEAR ANTIBODY INFLUENCE THE THERAPEUTIC RESULTS

被引:0
|
作者
MENARD, H
MATHIEU, J
MEDICIS, RD
LUSSIER, A
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:156 / 162
页数:7
相关论文
共 50 条
  • [21] Combination therapy with disease modifying anti-rheumatic drugs in rheumatoid arthritis
    Garrood, T
    Scott, DL
    BIODRUGS, 2001, 15 (08) : 543 - 561
  • [22] Effect of Anti-Rheumatic Drugs on Cardiovascular Disease Events in Rheumatoid Arthritis
    Baoqi, Yang
    Dan, Ma
    Xingxing, Zhao
    Xueqing, Zhu
    Yajing, Wang
    Ke, Xu
    Liyun, Zhang
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 8
  • [23] Combination Therapy with Disease Modifying Anti-Rheumatic Drugs in Rheumatoid Arthritis
    Toby Garrood
    David L. Scott
    BioDrugs, 2001, 15 : 543 - 561
  • [24] ARE ANTI-NUCLEAR FACTORS A CONTRAINDICATION FOR PENICILLAMINE TREATMENT IN PATIENTS WITH RHEUMATOID-ARTHRITIS
    SCHERAK, O
    HIESBERGER, H
    KOLARZ, G
    WIENER KLINISCHE WOCHENSCHRIFT, 1978, 90 (03) : 95 - 96
  • [25] EFFECT OF ANTI-RHEUMATIC THERAPY ON COLLAGEN-METABOLISM IN PATIENTS WITH RHEUMATOID-ARTHRITIS
    DORMIDONTOV, EN
    BARANOVA, EY
    KORSHUNOV, NI
    TERAPEVTICHESKII ARKHIV, 1979, 51 (07) : 44 - 47
  • [26] DRUG-CONTROL OF AN ANTI-RHEUMATIC IN RHEUMATOID-ARTHRITIS VIA SCINTIGRAPHY OF JOINTS
    KAFARNIK, D
    SEMMLER, U
    WIEGMANN, A
    PFANNENSTIEL, P
    AKTUELLE RHEUMATOLOGIE, 1979, 4 (03) : 133 - 137
  • [27] Disease-modifying anti-rheumatic drugs in rheumatoid arthritis and ankylosing spondylitis
    Haibel, H.
    Specker, C.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2009, 27 (04) : S159 - S163
  • [28] Assessment of adherence to disease-modifying anti-rheumatic drugs in rheumatoid arthritis
    Monchablon, Clelia
    Gonde, Henri
    Pouplin, Sophie
    Varin, Remi
    Vittecoq, Olivier
    Lequerre, Thierry
    CLINICAL RHEUMATOLOGY, 2020, 39 (01) : 207 - 216
  • [29] Monotherapy with biologic disease-modifying anti-rheumatic drugs in rheumatoid arthritis
    Choy, Ernest
    Aletaha, Daniel
    Behrens, Frank
    Finckh, Axel
    Gomez-Reino, Juan
    Gottenberg, Jacques-Eric
    Schuch, Florian
    Rubbert-Roth, Andrea
    RHEUMATOLOGY, 2017, 56 (05) : 689 - 697
  • [30] Toxicity of anti-rheumatic drugs in a randomized clinical trial of early rheumatoid arthritis
    van Jaarsveld, CHM
    Jahangier, ZN
    Jacobs, JWG
    Blaauw, AAM
    van Albada-Kuipers, GA
    ter Borg, EJ
    Brus, HLM
    Schenk, Y
    van der Veen, MJ
    Bijlsma, JWJ
    RHEUMATOLOGY, 2000, 39 (12) : 1374 - 1382